CarePassport x BioIntelliSense

Leveraging Lessons Learned During COVID-19 to Improve the Future of Virtual Care Management

CarePassport–a leading patient engagement developer–and BioIntelliSense–a continuous health monitoring and clinical intelligence company–have extended their collaboration with Mass General Hospital and CIDH to leverage learnings from a COVID-19 pilot study, to focus on improving the future of virtual care management and bring next-generation solutions to the forefront.

Moving forward, this collaboration will design the technology platform to empower providers with tools to accurately track population health data across all specialties, improve overall patient outcomes, and enable patients to become more directly involved with their own care. Additional work will focus on technical advances in preventative and coordinated care, as well as the development of specialty products for critical diagnostics or diseases. Projects will include the development of a pediatric app to help parents track their children’s health and quickly and securely relay important health information to their providers, and an app to better manage patients with Atrial Fibrillation (AFib), streamlining access to a patient’s health data from different wearables and third-party apps from a single login.

Combining the CarePassport platform and BioIntelliSense BioButton, there is further potential to create tools for disease tracking and community wellness by healthcare facilities and government entities, as well as schools, businesses, and other services. Future research also will look at geolocation capabilities that can provide a proactive view into real-time population data, decision support, and real-time monitoring abilities.